Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders

Details for Australian Patent Application No. 2005308538 (hide)

Owner Melendez Hevia, E.

Inventors Melendez Hevia, Enrique

Agent Shelston IP

Pub. Number AU-A-2005308538

PCT Pub. Number WO2006/056888

Priority 60/599,908 09.08.04 US

Filing date 8 August 2005

Wipo publication date 1 June 2006

International Classifications

A61K 31/198 (2006.01)

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/04 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

5 April 2007 PCT application entered the National Phase

  PCT publication WO2006/056888 Priority application(s): WO2006/056888

2 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005308539-Method and composition for enhancing anti-angiogenic therapy

2005308534-N- [ (3S)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake in- hibitors